ACRS
Aclaris Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$6.17
+3.70%Margins
Gross margin
95.6%
EBITDA margin
-913.9%
EBIT margin
-1050.2%
Net margin
-921.5%
FCF margin
-756.5%
-60.8%
Return on equity
-42.1%
Return on assets
-69.3%
Return on invested capital
0.04x
Asset turnover
-$62.1M
Cash from operations
$0.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026